BTX-011

N/A

Report date: 2024/04/26 17:58:27
NME

Base Information

Drug NameBTX-011
Drug Alias NameBTX-011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA polymerase theta inhibitors
TargetsDNA polymerase theta
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBreakpoint Therapeutics GmbH
China Registration ClassN/A

Develop Information

Active CompaniesBreakpoint Therapeutics GmbH
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A